Login

BWRX300: Promising SMR by GE Hitachi | GE Hitachi - Vice President of Small Modular Reactors 00:10:00

Share On Facebook Share On Twitter

GE Hitachi is the Vice President of Small Modular Reactors

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
QC Copper and Gold: Advancing the Open Misca Project in Quebec
00:10:00
Cardinal Energy Limited ASX:CE1 - A few words from Chairman, Glenn Whiddon | M. Scott Ratushny, CEO, Cardinal Energy Ltd (Alberta)CJ:TOR
00:10:00
The interviews feature Brian Spear of Sunrise Capital Investors and LP Investor Advisor Aleksey Chernobelskiy of Centrio Capital Partners.
00:10:00
Navigating Hedge Fund Startups: Insights on ADV Forms and Compliance | Turn Key Hedge Funds - Launch Consultant
00:10:00
Lassila & Tikanoja CEO's review from 2013 provides an overview of the company's operations and strategic direction.
00:10:00
The day After Tomorrow Transforming Building Production|Michael Marks,Founding Managing Partner,Celesta (fka WRVI)
00:10:00
The Money Couple: Scott and Bethany Palmer on Building Financial Intimacy in Marriage
00:10:00
Their portfolio includes 51 companies valued at over $1 billion|Tim Chae,Managing Partner,500 Global
00:10:00
Lithium Prices Rebound Amid Surging Global EV Demand and Strategic Policy Support
00:10:00
Adapting Strategies: Market Lessons and Future Outlooks | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Counting Our Blessings: End-of-Year Checklist and Financial Guidance
00:10:00
Leading the Global Market with Premium Zircon from Indonesia's Mandiri Sands | Oliver Hasler, CEO , PYX Resources Ltd.

© 2026 Nehu